Fatal Hemorrhage from Androgen-Related Hepatic Adenoma after Hematopoietic Cell Transplantation

Ashish R. Kumar, John E. Wagner, Arleen D. Auerbach, James E. Coad, Charles A. Dietz, Sarah J. Schwarzenberg, Margaret L. MacMillan

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Fanconi anemia is a rare genetic disorder that leads to bone marrow failure. Hematopoietic cell transplantation (HCT) is currently the only treatment option with curative potential. When a suitable HLA-matched sibling donor is not available, patients are often treated with androgenic steroids before considering HCT. Such androgen treatments can lead to the development of hepatic adenomas, which usually regress upon stopping androgen therapy. A patient with Fanconi anemia is described who underwent an unrelated umbilical cord blood transplant with a history of a hepatic adenoma related to androgen therapy. No adenomas were detected on an ultrasound examination prior to HCT. Soon after HCT, he died due to sudden rupture and hemorrhage of a hepatic adenoma. This case illustrates the need for extra vigilance in the detection and management of hepatic adenomas in patients treated with androgens, especially prior to HCT.

Original languageEnglish (US)
Pages (from-to)16-18
Number of pages3
JournalJournal of pediatric hematology/oncology
Issue number1
StatePublished - Jan 2004


  • Androgen therapy
  • Children
  • Fanconi anemia
  • Hematopoietic cell transplantation
  • Hepatic adenoma


Dive into the research topics of 'Fatal Hemorrhage from Androgen-Related Hepatic Adenoma after Hematopoietic Cell Transplantation'. Together they form a unique fingerprint.

Cite this